Sarah Kim-McOlash

Infantile gangliosidoses: Mapping a timeline of clinical changes

Jeanine Utz, Sarah Kim-McOlash, Kelly King et al. · Molecular Genetics and Metabolism · 2017 · 87 citations · Full text

Medicine, Neurology, Pediatrics +10

A Highly Efficacious PS Gene Editing System Corrects Metabolic and Neurological Complications of Mucopolysaccharidosis Type I

Li Ou, Michael J. Przybilla, Ozan Ahlat et al. · Molecular Therapy · 2020 · 57 citations · Full text

Life Sciences, Biotechnology, Molecular Biology +17

Use of Titration as a Therapeutic Individualization Strategy: An Analysis of Food and Drug Administration–Approved Drugs

Robert N. Schuck, Michael Pacanowski, Sarah Kim-McOlash et al. · Clinical and Translational Science · 2019 · 24 citations · Full text

Medicine, Pharmacology, Clinical Pharmacology +15

The juvenile gangliosidoses: A timeline of clinical change

Kelly King, Sarah Kim-McOlash, Chester B. Whitley et al. · Molecular Genetics and Metabolism Reports · 2020 · 17 citations · Full text

Medicine, Neurology, Pediatrics +13

FDA Approval Summary: Tovorafenib for Relapsed or Refractory BRAF-Altered Pediatric Low-Grade Glioma

Sonia Singh, Diana Bradford, Somak Chatterjee et al. · Clinical Cancer Research · 2025 · 17 citations · Full text

Medicine, Oncology, Pharmacology +15